IP Library Granted Patent US 8,044,195
Granted Patent B2
US 8,044,195 · App. 12/759,073 · Granted Oct 25, 2011

Cross-linked glycopeptide-cephalosporin antibiotics

Assignee: Theravance, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,044,195
App. No.
12/759,073
Granted
Oct 25, 2011
Kind
B2
Abstract

This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

Claims (4)

1. A compound of the formula:

or a pharmaceutically-acceptable salt thereof.

2. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a compound of the formula:

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0484 →
Continuity (5)
Continuation 11895534 · Aug 24, 2007
Division 11172303 · Jun 30, 2005
Continuation 10269471 · Oct 11, 2002
Provisional Application 60328889 · Oct 12, 2001
Related Publication 20100197569A1 · Aug 5, 2010